This page brings together the European Medicines Agency's (EMA) latest information on diseases causing problems with the brain and nervous system, including Alzheimer's disease, Parkinson's disease and multiple sclerosis. It lists:
- the newest and most recently updated medicines authorised for the treatment of neurodegenerative diseases in the European Union (EU);
- any recent opinions on medicines for neurodegenerative diseases that are pending authorisation by the European Commission (EC);
- EMA's latest news announcements related to neurodegenerative diseases;
- EMA's events on topics related to neurodegenerative diseases.